investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Stanford Molecular and Cellular Characterization Laboratory
James D. Brooks
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
James D. Brooks
Stanford University
Stanford, United States
Related projects
Areti Strati
Molecular Characterization of CTC in Prostate Cancer
Prostate
William Figg
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies
Prostate
Pathology
Hematology and hematologic malignancies
Peter S. Nelson
Non Invasive Biomarkers for Diagnosing Clinically Significant Prostate Cancer
Prostate
Adam De La Zerda
Molecular Imaging of Protein Glycosylation in Living Subjects
Prostate
Hans Schreiber
Immunology of Unique Tumor Specific Antigens
Prostate
Tony R Hunter
Signal Transduction by Tyrosine Phosphorylation
Prostate
Radoslav Goldman
Basic Cancer Research in Cancer Health Disparities
Prostate
Pathology
Jeffrey Gildersleeve
Serum Antibody Profiling with a Carbohydrate Microarray
Prostate
Pathology
Pengda Liu
Elucidating a Novel Akt Activation Mechanism for Targeted Prostate Cancer Therapy
Prostate